Results 181 to 190 of about 1,448,184 (405)
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang +9 more
wiley +1 more source
All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
Jaya Sangodkar +5 more
semanticscholar +1 more source
This study demonstrates that cholesterol in messenger RNA‐lipid nanoparticles (mRNA‐LNPs) can be completely replaced with an immunopotentiating lipid, i.e., a synthetic analogue of the C‐type lectin receptor agonist monomycoloyl glycerol (MMG‐1), without compromising physicochemical properties, in vivo transfection efficiency, and immunogenicity of the
Abhijeet G. Lokras +19 more
wiley +1 more source
The Histochemical Localization of Alkaline Phosphatase in Tooth Supporting Tissues of Rat
Syoichi SUGA +2 more
openalex +2 more sources
The Plasma Phosphatase in Rickets and Scurvy [PDF]
Jr. Smith, Montague Maizels
openalex +1 more source
A potent anionic citric acid‐based 3D‐printed scaffold is developed for the sustained and controlled release of orthobiologics to enhance orthopedic therapeutic efficacy. Comprehensive in vivo studies demonstrated effective bone fusion and high safety at a low dose of BMP‐2 delivered by the system, establishing it as a promising platform for safe ...
Se‐Hwan Lee +12 more
wiley +1 more source
Reactivation of alkaline phosphatases after dialysis [PDF]
M. A. M. Abul-Fadl, E. J. King
openalex +1 more source

